Utah Code § 58-37-109

Listed controlled substances.

Last amended: 2026Year: 2026Length: 271 wordsOfficial source
The following substances, their analogs, homologs, and synthetic equivalents, are listed controlled substances: (1) AB-001; (2) AB-PINACA; N-[1-(aminocarbonyl)-2-methylpropyl]-1-pentyl-1H-indazole-3-carboxamide; (3) AB-FUBINACA; N-[1-(aminocarbonyl)-2-methylpropyl]-1-[(4-fluorophenyl) methyl]-1H-indazole-3-carboxamide; (4) AB-CHMINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide); (5) ADB-CHMINACA (N-[(2S)-1-amino-3,3-dimethyl-1-oxobutan-2-yl]-1- (cyclohexylmethyl)indazole-3-carboxamide); (6) ADB-FUBINACA (N-(1-amino-3,3-dimethyl-1oxobutan-2-yl)-1- (4-fluorobenzyl)-1H-indazole-3-caboxamide); (7) AKB48; (8) alpha-Pyrrolidinohexanophenone (alpha-PHP) (1-Phenyl-2-(pyrrolidin-1-yl)hexan-1-one); (9) alpha-Pyrrolidinovalerophenone (alpha-PVP); (10) AM-694 (1-[(5-fluoropentyl)-1H-indol-3-yl]-(2-iodophenyl)methanone); (11) AM-1248; (12) AM-2201 (1-(5-fluoropentyl)-3-(1-naphthoyl)indole); (13) AM-2233; (14) AM-679; (15) A796,260; (16) Butylone; (17) CP 47,497 and its C6, C8, and C9 homologs (2-[(1R,3S)-3-hydroxycyclohexyl] -5-(2-methyloctan-2-yl)phenol); (18) Diisopropyltryptamine (DiPT); (19) Ethylone; (20) Ethylphenidate; (21) Fluoroisocathinone; (22) Fluoromethamphetamine; (23) Fluoromethcathinone; (24) FUB-AMB; methyl (1-(4-fluorobenzyl)-1H-indazole-3-carbonyl)valinate; (25) HU-210; (6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl) -6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol; (26) HU-211; Dexanabinol,(6aS,10aS)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol; (27) JWH-015; (2-methyl-1-propyl-1H-indol-3-yl)-1-naphthalenyl-methanone; (28) JWH-018; Naphthalen-1-yl-(pentylindol-3-yl)methanone {also known as 1-Pentyl-3-(1-naphthoyl)indole}; (29) JWH-019; 1-hexyl-3-(1-naphthoyl)indole; (30) JWH-073; Naphthalen-1-yl(1-butylindol-3-yl)methanone {also known as 1-Butyl-3-(1-naphthoyl)indole}; (31) JWH-081; 4-methoxynaphthalen-1-yl-(1-pentylindol-3-yl)methanone; (32) JWH-122; CAS#619294-47-2; (1-Pentyl-3-(4-methyl-1-naphthoyl)indole); (33) JWH-200; 1-(2-(4-(morpholinyl)ethyl))-3-(1-naphthoyl)indole; (34) JWH-203; 1-pentyl-3-(2-chlorophenylacetyl)indole; (35) JWH-210; 4-ethyl-1-naphthalenyl(1-pentyl-1H-indol-3-yl)-methanone; (36) JWH-250; 1-pentyl-3-(2-methoxyphenylacetyl)indole; (37) JWH-251; 2-(2-methylphenyl)-1-(1-pentyl-1H-indol-3-yl)ethanone; (38) JWH-398; 1-pentyl-3-(4-chloro-1-naphthoyl)indole; (39) MAM-2201; (40) MAM-2201; (1-(5-fluoropentyl)-1H-indol-3-yl)(4-ethyl-1-naphthalenyl)-methanone; (41) Methoxetamine; (42) Naphyrone; (43) PB-22; 1-pentyl-1H-indole-3-carboxylic acid 8-quinolinyl ester; (44) Pentedrone; (45) Pentylone; (46) RCS-4; 1-pentyl-3-(4-methoxybenzoyl)indole; (47) RCS-8; 1-(2-cyclohexylethyl)-3-(2-methoxyphenylacetyl)indole {also known as BTW-8 and SR-18}; (48) STS-135; (49) UR-144; (50) UR-144 N-(5-chloropentyl) analog; (51) XLR11; (52) 2C-C; (53) 2C-D; (54) 2C-E; (55) 2C-H; (56) 2C-I; (57) 2C-N; (58) 2C-P; (59) 2C-T-2; (60) 2C-T-4; (61) 2NE1; (62) 25I-NBOMe; (63) 2,5-Dimethoxy-4-chloroamphetamine (DOC); (64) 4-Fluoro MDMB-BUTINACA (Methyl 2-(1-(4-fluorobutyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate); (65) 4-methylmethcathinone {also known as mephedrone}; (66) 3,4-methylenedioxypyrovalerone {also known as MDPV}; (67) 3,4-Methylenedioxymethcathinone {also known as methylone}; (68) 4-methoxymethcathinone; (69) 4-Methyl-alpha-pyrrolidinopropiophenone; (70) 4-Methylethcathinone; (71) 5F-AKB48; 1-(5-flouropentyl)-N-tricyclo[3.3.1.13,7]dec-1-yl-1H-indazole-3- carboxamide; (72) 5-Fluoro ADB (Methyl N-{[1-(5-fluoropentyl)-1H-indazol-3-yl]carbonyl}-3-methyl-valinate); (73) 5-Fluoro AMB (Methyl N-{[1-(5-fluoropentyl)-1H-indazol-3-yl]carbonyl}valinate); (74) 5-fluoro-PB-22; 1-(5-fluoropentyl)-1H-indole-3-carboxylic acid 8-quinolinyl ester; (75) 5-Iodo-2-aminoindane (5-IAI); (76) 5-MeO-DALT; (77) 25B-NBOMe; 2-(r-bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl) methyl]ethanamine; (78) 25C-NBOMe; 2-(4Chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl) methyl]ethanamine; and (79) 25H-NBOMe; 2-(2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine.
Utah Code § 58-37-109: Listed controlled substances. | Justis AI